Inflammation - Allinky Biopharma

Go to content

Main menu:

AIK3 is a proprietary family of therapeutic compounds (small molecules) that selectively bind to the p38 and JNK MAP Kinases at a novel allosteric site discovered by Allinky. These compounds have been effective in different animal models of neurodegeneration and inflammation, exerting no toxicity due to its selective and exclusive mode of action. Also, Allinky is assessing the efficacy of these molecules in the treatment of respiratory diseases such as COPD and IPF.

 
 
 
Back to content | Back to main menu